|
Garheng Kong, MD, PhD, MBA, General Partner, joined Intersouth Partners in 2000. He has board involvement with most of Intersouth’s life science companies. Garheng has full-cycle investing experience, successfully sourcing, syndicating, managing and exiting investments. He has also served as interim CEO for two Intersouth portfolio companies. Prior to Intersouth, Garheng worked at GlaxoWellcome and McKinsey & Company. Garheng received his M.D., Ph.D. in Biomedical Engineering, and M.B.A. from Duke University graduating at the top of his medical and business school classes. He also holds a B.S. in Chemical Engineering and a B.S. in Biological Sciences from Stanford University. He is active in the community and currently serves on the board of directors of the North Carolina Medical Device Organization, the SEBIO organization, the Corporate Chaplains of America and has served on the Duke University Medical Center Institutional Review Board. Garheng is also on faculty at the Duke School of Business as a Senior Scholar. | 